Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
9138studies shown
Showing 5,629-5,640 of 9,138
Drug study icon
CompletedNCT00868959

Lurasidone - A 24-week Extension Study of people with Bipolar I Depression

This study is completed. It focuses on bipolarity and currently lists study information in Canada, Colombia, Czech Republic, France, India, Japan, Lithuania, Peru, Poland, Romania, Russian Federation, Slovakia, South Africa, Ukraine, and the United States.

Multiple locations, including Little Rock
Bipolarity, DepressionOtherFrom 18 Years to 75 Years
Countries
United States, France, Canada, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00868452

Lurasidone - A 6-week Study of people with Bipolar I Depression (Add-on)

This study is completed. It focuses on bipolarity and currently lists study information in Czech Republic, France, Germany, India, Poland, Romania, Russian Federation, South Africa, Ukraine, and the United States.

Multiple locations, including Little Rock
Bipolarity, DepressionOtherFrom 18 Years to 75 Years
Countries
United States, France, Czech Republic, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00868699

Lurasidone - A 6-week Study of people with Bipolar I Depression (Monotherapy)

This study is completed. It focuses on bipolarity and currently lists study information in Czech Republic, France, India, Romania, Russian Federation, South Africa, Ukraine, and the United States.

Multiple locations, including Escondido
Bipolarity, DepressionOtherFrom 18 Years to 75 Years
Countries
United States, France, Czech Republic, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT02147379

Lurasidone and Cognition in Bipolarity I

This study is completed. It focuses on bipolarity and currently lists study information in Canada.

In Vancouver
BipolarityOtherFrom 19 Years to 65 Years
Countries
Canada
Sponsor
University of British Columbia
Condition
Bipolarity
Drug study icon
CompletedNCT01485640

Lurasidone Extended Use Study

This study is completed. It focuses on schizophrenia and currently lists study information in Canada, Colombia, Czech Republic, France, India, Lithuania, Romania, Russian Federation, Serbia, Slovakia, South Africa, and Ukraine.

Multiple locations, including Kelowna
Schizophrenia, BipolarityOther
Countries
France, Canada, Colombia, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT06527885

Lurasidone Non-Interventional Study in Schizophrenia Patients

This study is completed. It focuses on schizophrenia and currently lists study information in Italy.

Multiple locations, including Brescia
SchizophreniaOtherFrom 18 Years to 99 Years
Countries
Italy
Sponsor
Aziende Chimiche Riunite Angelini Francesco S.p.A
Condition
Schizophrenia
Drug study icon
CompletedNCT02046369

Lurasidone Pediatric Bipolar Study

This study is completed. It focuses on bipolarity and currently lists study information in Bulgaria, Colombia, France, Hungary, Mexico, the Philippines, Poland, the United States, South Korea, and Ukraine.

Multiple locations, including Dothan
Bipolarity, DepressionOtherFrom 10 Years to 17 Years
Countries
United States, France, Bulgaria, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01620060

Lurasidone Pediatric Pharmacokinetics Study

This study is completed. It focuses on schizophrenia and currently lists study information in the United States.

Multiple locations, including Little Rock
SchizophreniaOtherFrom 6 Years to 17 Years
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia
Other study type icon
CompletedNCT05204407

Luteolin for People With Schizophrenia

This study is completed. It focuses on schizophrenia and currently lists study information in the United States.

Multiple locations, including Los Angeles
SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Other study type icon
CompletedNCT05105542

M1 Schizophrenia PET Study

This study is completed. It focuses on schizophrenia and currently lists study information in the United States.

In New Haven
SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
Mental Health | Clinical Trials | HopeStage Research